Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

15.26 USD +0.01 (+0.07%)
Streaming Delayed Price Updated: 7:02 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,986
Open 15.25
Bid (Size) 15.34 (40)
Ask (Size) 15.91 (1)
Prev. Close 15.25
Today's Range 14.80 - 15.60
52wk Range 10.86 - 22.22
Shares Outstanding 67,553,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Coherus Management to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
Coherus BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results
From GlobeNewswire News Releases

Performance

YTD
-9.76%
-9.76%
1 Month
-25.31%
-25.31%
3 Month
-18.05%
-18.05%
6 Month
-19.56%
-19.56%
1 Year
-25.12%
-25.12%

More News

Read More
Coherus BioSciences to Report Fourth Quarter and Full Year 2020 Financial Results on February 24th
From GlobeNewswire News Releases
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
From GlobeNewswire News Releases
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 Antibody, Toripalimab, in U.S. and Canada
From GlobeNewswire News Releases
Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi Biosciences’ PD-1, toripalimab, in United States and Canada
From GlobeNewswire News Releases
Coherus BioSciences Announces New Employment Inducement Grants
From GlobeNewswire News Releases
Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors
From GlobeNewswire News Releases
Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
Coherus BioSciences Inc (CHRS) Q4 2020 Earnings Call Transcript
Tags Market News CHRS
From Motley Fool
Week in Review: Junshi Signs $1.1 Billion Deal for US-Canada Rights to PD-1
From ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.